Utilization of the caspase-8 null neuroblastoma cell line, NB7, and the same line reconstituted with either wild-type or a catalytically inactive point mutant of caspase-8 (C360A) [5] in parallel allows the identification of chemical agents that act specifically via the caspase-8 apoptotic pathway. Here, CASP8 is linked to neuroblastoma.